- Home
- GNRC vs RVTY Comparison
GNRC vs RVTY Comparison
Compare GNRC & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNRC | RVTY |
|---|---|---|
| Founded | 1959 | 1937 |
| Country | United States | United States |
| Employees | 9400 | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 11.6B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | GNRC | RVTY |
|---|---|---|
| Price | $252.96 | $113.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 16 |
| Target Price | ★ $211.75 | $109.67 |
| AVG Volume (30 Days) | 904.0K | ★ 1.4M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $17.36 | $6.37 |
| Revenue Next Year | $12.51 | $5.10 |
| P/E Ratio | ★ $84.89 | $313.47 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $134.80 | $81.22 |
| 52 Week High | $296.44 | $118.30 |
Technical Indicators
Market Signals| Indicator | GNRC | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 66.78 |
| Support Level | $237.59 | $95.31 |
| Resistance Level | $295.31 | $118.30 |
| Average True Range (ATR) | 13.37 | 3.88 |
| MACD | -2.28 | 0.96 |
| Stochastic Oscillator | 8.66 | 81.74 |
Price Performance
Historical ComparisonAbout GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.